A new global research consortium is being established to address the global impact of Antimicrobial resistance. Centres for Antimicrobial Optimisation Network (CAMO-NET), brings together research teams from the University of Liverpool and Imperial College London in the UK, the University of Cape Town in South Africa, the Infectious Diseases Institute in Uganda and the Faculty of Medicine at the University of São Paulo in Brazil.o including three ‘Shadow National Sites. Researchers here will seek to build knowledge relating to the optimised use of antibiotics, improve access to effective treatment and better prevention and treatment of bacterial infections, all of which will minimise Antimicrobial resistance. This will take into account specific epidemiological, cultural, structural, and economic factors. The initiative will help to improve clinical decision-making regarding antimicrobial use and also inform practices and guidelines for prescribers, users and policymakers.
Link to the article: bit.ly/3NvLKhU
Published On: /05/2023
